AstraZeneca PLC Sues Former Exec After GlaxoSmithKline Poaches Him Away to Run Its Largest Business

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-astrazeneca.jpg" NAME"AstraZeneca Sues Former Exec After GlaxoSmithKline Poaches Him Away to Run Its Largest Business" ALT"AstraZeneca Sues Former Exec After GlaxoSmithKline Poaches Him Away to Run Its Largest Business"May…

Continue ReadingAstraZeneca PLC Sues Former Exec After GlaxoSmithKline Poaches Him Away to Run Its Largest Business

New FDA Head's First Order of Business: Inspection Staff Reorg and Lower Drug Prices

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-fda.jpg" NAME"New FDA Head's First Order of Business: Inspection Staff Reorg and Lower Drug Prices" ALT"New FDA Head's First Order of Business: Inspection Staff Reorg and Lower Drug Prices"May…

Continue ReadingNew FDA Head's First Order of Business: Inspection Staff Reorg and Lower Drug Prices

3 Rock-Bottom Biotechs That Big Market Players are Betting On

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-investor.jpg" NAME"3 Rock-Bottom Biotechs That Big Market Players are Betting On" ALT"3 Rock-Bottom Biotechs That Big Market Players are Betting On"May 16, 2017By Mark Terry, BioSpace.com Breaking News StaffAssumption...…

Continue Reading3 Rock-Bottom Biotechs That Big Market Players are Betting On

With Plans for U.S. and China Manufacturing Plants, Athenex Gears Up for $100 Million IPO

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks.jpg" NAME"With Plans for U.S. and China Manufacturing Plants, Athenex Gears Up for $100 Million IPO" ALT"With Plans for U.S. and China Manufacturing Plants, Athenex Gears Up for $100…

Continue ReadingWith Plans for U.S. and China Manufacturing Plants, Athenex Gears Up for $100 Million IPO